Literature DB >> 22449769

Recent progress in the understanding and treatment of nonepileptic seizures.

Markus Reuber1, Rebecca Mayor.   

Abstract

PURPOSE OF REVIEW: There has been a steady increase in the number of publications about (psychogenic) nonepileptic seizures (NES) over the past two decades. This review focuses on work published in the past 3 years. It summarizes the most important developments in terms of diagnosis, cause, clinical manifestations and treatment of NES. RECENT
FINDINGS: Several recent studies demonstrate the scope and limitation of questionnaire-based and conversation analytic approaches to the differential diagnosis of epilepsy and NES. Experimental work has revealed that patients with NES have increased levels of physiological arousal at rest which are associated with abnormal mental processing. There is a growing understanding of the meaning and clinical significance of the heterogeneous manifestations of NES. Several studies document the therapeutic potential of an early and effective communication of the diagnosis of NES. A number of randomized controlled or uncontrolled long-term follow-up pilot studies suggest that different forms of psychotherapy are effective for NES.
SUMMARY: Recent research has improved our understanding of NES as a biopsychosocial disorder. Clear diagnostic and management pathways for patients with NES are likely to emerge in the near future.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22449769     DOI: 10.1097/YCO.0b013e3283523db6

Source DB:  PubMed          Journal:  Curr Opin Psychiatry        ISSN: 0951-7367            Impact factor:   4.741


  8 in total

Review 1.  Ethical dilemmas in pediatric and adolescent psychogenic nonepileptic seizures.

Authors:  Cristie M Cole; Tatiana Falcone; Rochelle Caplan; Jane Timmons-Mitchell; Kristine Jares; Paul J Ford
Journal:  Epilepsy Behav       Date:  2014-07-10       Impact factor: 2.937

2.  Nocturnal paroxysmal events in an 8-year-old girl.

Authors:  Lourdes M DelRosso; Lei Wang; Romy Hoque
Journal:  J Clin Sleep Med       Date:  2013-02-01       Impact factor: 4.062

3.  Closing the Major Gap in PNES Research: Finding a Home for a Borderland Disorder.

Authors:  Brien J Smith
Journal:  Epilepsy Curr       Date:  2014-03       Impact factor: 7.500

4.  COgnitive behavioural therapy vs standardised medical care for adults with Dissociative non-Epileptic Seizures (CODES): a multicentre randomised controlled trial protocol.

Authors:  Laura H Goldstein; John D C Mellers; Sabine Landau; Jon Stone; Alan Carson; Nick Medford; Markus Reuber; Mark Richardson; Paul McCrone; Joanna Murray; Trudie Chalder
Journal:  BMC Neurol       Date:  2015-06-27       Impact factor: 2.474

5.  COgnitive behavioural therapy versus standardised medical care for adults with Dissociative non-Epileptic Seizures (CODES): statistical and economic analysis plan for a randomised controlled trial.

Authors:  Emily J Robinson; Laura H Goldstein; Paul McCrone; Iain Perdue; Trudie Chalder; John D C Mellers; Mark P Richardson; Joanna Murray; Markus Reuber; Nick Medford; Jon Stone; Alan Carson; Sabine Landau
Journal:  Trials       Date:  2017-06-06       Impact factor: 2.279

Review 6.  Psychogenic Nonepileptic Seizures and Psychosocial Management: A Narrative Review.

Authors:  Nisha Phakey; Karishma Godara; Divyani Garg; Suvasini Sharma
Journal:  Ann Indian Acad Neurol       Date:  2021-03-31       Impact factor: 1.383

Review 7.  Ocular Manifestations and Therapeutic Options in Patients with Familial Amyloid Polyneuropathy: A Systematic Review.

Authors:  A C Martins; A M Rosa; E Costa; C Tavares; M J Quadrado; J N Murta
Journal:  Biomed Res Int       Date:  2015-10-19       Impact factor: 3.411

Review 8.  Ocular Involvement in Hereditary Amyloidosis.

Authors:  Angelo Maria Minnella; Roberta Rissotto; Elena Antoniazzi; Marco Di Girolamo; Marco Luigetti; Martina Maceroni; Daniela Bacherini; Benedetto Falsini; Stanislao Rizzo; Laura Obici
Journal:  Genes (Basel)       Date:  2021-06-22       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.